SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-21-115108
Filing Date
2021-09-13
Accepted
2021-09-13 16:31:10
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2127361-1_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2127361-1_3aseq1.xml 3/A 12544
2 EXHIBIT 24.1 tm2127361d1_ex24-1.htm EX-24.1 9860
  Complete submission text file 0001104659-21-115108.txt   23792
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Feinberg Peter (Reporting) CIK: 0001870076 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40675 | Film No.: 211250018